Showing 521 - 540 results of 139,850 for search '(( 50 ((n decrease) OR (a decrease)) ) OR ( 10 ((we decrease) OR (mean decrease)) ))', query time: 1.27s Refine Results
  1. 521

    Inhibition of GLS1 decreases the proportion of CCR6 and CXCR3 expressing CD4<sup>+</sup> T cells. by Zeynep Sener (3146064)

    Published 2016
    “…(B–C) The proportion of CCR6 expressing cells at day 3 (left) and day 5 (right) under normoxia (black bars) and hypoxia (grey bars) in the presence (+) and absence (-) of 25 μM BPTES and 50 μM 968. BPTES and 968 significantly decrease the proportion of CCR6 expressing cells under normoxia both at day 3 and 5, whereas 968 but not BPTES decrease the proportion of CCR6 expressing cells under hypoxia both at day 3 and 5. …”
  2. 522
  3. 523

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    “…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”
  4. 524

    Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced SG formation in LSM12-depleted cells. by Jongbo Lee (9914603)

    Published 2020
    “…All underlying numerical values are available in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001002#pbio.3001002.s016" target="_blank">S1 Data</a>. …”
  5. 525
  6. 526
  7. 527
  8. 528
  9. 529
  10. 530
  11. 531

    Erratum: Decrease in Incidence of Bronchopulmonary Dysplasia with Erythropoietin Administration in Preterm Infants: A Retrospective Study by Rayjada N. (4272919)

    Published 2017
    “…<b><i>Objective:</i></b> To determine whether EPO treatment for AOP was associated with a reduced incidence of BPD in premature infants. …”
  12. 532
  13. 533
  14. 534
  15. 535
  16. 536
  17. 537
  18. 538
  19. 539
  20. 540